No Data
Cogent Biosciences Secures Long-Term Bezuclastinib Supply Deal
Cogent Biosciences Enters Commercial Supply Agreement With Hovione FarmaCiencia
Cogent Biosciences (COGT) said Wednesday in a filing that it entered into a commercial supply agreement with Hovione FarmaCiencia on Tuesday to manufacture bezuclastinib spray-dried dispersion and
Express News | Cogent Biosciences - Enters Commercial Supply Agreement With Hovione on Sept 1, 2026 - SEC Filing
$100 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today
Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 22.44% on an annualized basis producing an average annual return of 33.55%. Currently, Cogent Biosciences has a
Cogent Biosciences Insider Sold Shares Worth $1,689,493, According to a Recent SEC Filing
Arlene Morris, Director, on August 27, 2026, sold 45,510 shares in Cogent Biosciences (COGT) for $1,689,493.SEC Filing:https://www.sec.gov/Archives/edgar/data/1622229/000119312526377001/xslF345X05/
SA Asks: What Are the Most Promising Oncology Companies Right Now?